Menu
← Oncology Approval Tracker
FDA DECISION ·
Ibrutinib (generic Imbruvica)
ibrutinib · Zydus Worldwide
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Imbruvica capsules for the original labeled adult uses, including mantle cell lymphoma, CLL or SLL, Waldenström macroglobulinemia, marginal zone lymphoma and chronic graft-versus-host disease.
LAMPGEN ANALYSIS
Why it matters
This records the first ANDA action for ibrutinib capsules. Individual disease indications have distinct regulatory histories.
What research teams should watch
Use the historical ANDA label by indication, and record market availability separately from the approval date.
PRIMARY RECORDS